Clinical Trial Update: Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia

View source ↗

Summary

A clinical trial update exploring the role of osteoprotegerin in bone health among women with congenital adrenal hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Osteoprotegerin (osteoprotegerin)

Snippet

Sponsor: Office of Rare Diseases (ORD) | Conditions: Adrenal Hyperplasia, Congenital | Status: UNKNOWN